285 related articles for article (PubMed ID: 30935074)
1. Stem Cell-Based Therapies for Multiple Sclerosis: Current Perspectives.
Cuascut FX; Hutton GJ
Biomedicines; 2019 Mar; 7(2):. PubMed ID: 30935074
[TBL] [Abstract][Full Text] [Related]
2. Current knowledge on multiple sclerosis pathophysiology, disability progression assessment and treatment options, and the role of autologous hematopoietic stem cell transplantation.
Gakis G; Angelopoulos I; Panagoulias I; Mouzaki A
Autoimmun Rev; 2024 Feb; 23(2):103480. PubMed ID: 38008300
[TBL] [Abstract][Full Text] [Related]
3. Stem Cell Therapy for Multiple Sclerosis.
Genc B; Bozan HR; Genc S; Genc K
Adv Exp Med Biol; 2019; 1084():145-174. PubMed ID: 30039439
[TBL] [Abstract][Full Text] [Related]
4. Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant.
Massey JC; Sutton IJ; Ma DDF; Moore JJ
Front Immunol; 2018; 9():410. PubMed ID: 29593711
[TBL] [Abstract][Full Text] [Related]
5. Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
Obradović D; Tukić L; Radovinović-Tasić S; Petrović B; Elez M; Ostojić G; Balint B
Vojnosanit Pregl; 2016 May; 73(5):504-8. PubMed ID: 27430119
[TBL] [Abstract][Full Text] [Related]
6. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Atkins HL; Bowman M; Allan D; Anstee G; Arnold DL; Bar-Or A; Bence-Bruckler I; Birch P; Bredeson C; Chen J; Fergusson D; Halpenny M; Hamelin L; Huebsch L; Hutton B; Laneuville P; Lapierre Y; Lee H; Martin L; McDiarmid S; O'Connor P; Ramsay T; Sabloff M; Walker L; Freedman MS
Lancet; 2016 Aug; 388(10044):576-85. PubMed ID: 27291994
[TBL] [Abstract][Full Text] [Related]
7. NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs.
Sormani MP; Muraro PA; Saccardi R; Mancardi G
Mult Scler; 2017 Feb; 23(2):201-204. PubMed ID: 27207454
[TBL] [Abstract][Full Text] [Related]
8. Autologous hematopoietic stem cell transplantation (AHSCT) for aggressive multiple sclerosis - whom, when and how.
Szczechowski L; Śmiłowski M; Helbig G; Krawczyk-Kuliś M; Kyrcz-Krzemień S
Int J Neurosci; 2016 Oct; 126(10):867-71. PubMed ID: 26577419
[TBL] [Abstract][Full Text] [Related]
9. Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis.
Mohammadi R; Aryan A; Omrani MD; Ghaderian SMH; Fazeli Z
Biologics; 2021; 15():53-59. PubMed ID: 33688164
[TBL] [Abstract][Full Text] [Related]
10. Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
Casanova B; Jarque I; Gascón F; Hernández-Boluda JC; Pérez-Miralles F; de la Rubia J; Alcalá C; Sanz J; Mallada J; Cervelló A; Navarré A; Carcelén-Gadea M; Boscá I; Gil-Perotin S; Solano C; Sanz MA; Coret F
Neurol Sci; 2017 Jul; 38(7):1213-1221. PubMed ID: 28396953
[TBL] [Abstract][Full Text] [Related]
11. [Immunoablation and autologous hematopoietic stem cell transplantation (AHSCT) in multiple sclerosis].
Créange A; Farge-Bancel D
Rev Neurol (Paris); 2008 Mar; 164(3):207-15. PubMed ID: 18405770
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.
Xiao J; Yang R; Biswas S; Qin X; Zhang M; Deng W
Int J Mol Sci; 2015 Apr; 16(5):9283-302. PubMed ID: 25918935
[TBL] [Abstract][Full Text] [Related]
13. Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis.
Lycke J; Lenhoff S
Ther Adv Neurol Disord; 2020; 13():1756286420929467. PubMed ID: 32636931
[TBL] [Abstract][Full Text] [Related]
14. Promises and Limitations of Neural Stem Cell Therapies for Progressive Multiple Sclerosis.
Pluchino S; Smith JA; Peruzzotti-Jametti L
Trends Mol Med; 2020 Oct; 26(10):898-912. PubMed ID: 32448751
[TBL] [Abstract][Full Text] [Related]
15. Does Resetting the Immune System Fix Multiple Sclerosis?
Bose G; Thebault SDX; Atkins HL; Freedman MS
Can J Neurol Sci; 2020 Jan; 47(1):1-10. PubMed ID: 31511117
[TBL] [Abstract][Full Text] [Related]
16. Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature.
Patti F; Chisari CG; Toscano S; Arena S; Finocchiaro C; Cimino V; Milone G
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207216
[TBL] [Abstract][Full Text] [Related]
17. Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis.
Bose G; Atkins HL; Bowman M; Freedman MS
Mult Scler; 2019 Nov; 25(13):1764-1772. PubMed ID: 30251913
[TBL] [Abstract][Full Text] [Related]
18. Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis.
Moore JJ; Massey JC; Ford CD; Khoo ML; Zaunders JJ; Hendrawan K; Barnett Y; Barnett MH; Kyle KA; Zivadinov R; Ma KC; Milliken ST; Sutton IJ; Ma DDF
J Neurol Neurosurg Psychiatry; 2019 May; 90(5):514-521. PubMed ID: 30538138
[TBL] [Abstract][Full Text] [Related]
19. A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells.
Shroff G
Stem Cells Cloning; 2018; 11():1-11. PubMed ID: 29483778
[TBL] [Abstract][Full Text] [Related]
20. The potential use of mesenchymal stem cells for the treatment of multiple sclerosis.
Mansoor SR; Zabihi E; Ghasemi-Kasman M
Life Sci; 2019 Oct; 235():116830. PubMed ID: 31487529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
